CC
TMO icon

Carlson Capital’s Thermo Fisher Scientific TMO Stock Holding History

Carlson Capital’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-58,518
Closed -$8.99M – 292
2017
Q1 		$8.99M Sell
58,518
-58,568
-50% -$8.95M 0.11% 202
2016
Q4 		$16.5M Buy
+117,086
New +$17.3M 0.2% 140
2015
Q2 		– Sell
-176,531
Closed -$23.7M – 347
2015
Q1 		$23.7M Sell
176,531
-27,044
-13% -$3.49M 0.26% 125
2014
Q4 		$25.5M Sell
203,575
-7,186
-3% -$874K 0.25% 136
2014
Q3 		$25.6M Buy
210,761
+46,921
+29% +$5.71M 0.28% 124
2014
Q2 		$19.3M Sell
163,840
-177,410
-52% -$20.9M 0.21% 152
2014
Q1 		$41M Buy
341,250
+123,300
+57% +$14.7M 0.48% 69
2013
Q4 		$24.3M Sell
217,950
-123,835
-36% -$12.3M 0.28% 131
2013
Q3 		$31.5M Buy
+341,785
New +$30.9M 0.42% 73

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Carlson Capital's TMO Position: Q2 2017 in Review

Carlson Capital sold out of Thermo Fisher Scientific (TMO) in Q2 2017, closing a stake of 58,518 shares — an estimated $8.99M sold.

Carlson Capital first reported a position in TMO in Q3 2013 and held it in 9 quarters. The position peaked at $41M in Q1 2014. 1,159 funds tracked by Wall St. Rank hold TMO as of Q2 2017.

  • Carlson Capital reported no remaining Thermo Fisher Scientific position as of Q2 2017 after selling out during the quarter.
  • Carlson Capital sold 58,518 Thermo Fisher Scientific shares in Q2 2017, an estimated $8.99M.
  • Carlson Capital first reported a position in Thermo Fisher Scientific in Q3 2013 and held it in 9 quarters.
  • Carlson Capital's Thermo Fisher Scientific position peaked at $41M in Q1 2014.
  • 1,159 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2017.

Based on Carlson Capital's 13F filing for Q2 2017, filed 14 Aug 2017.